In short

J9355 is the HCPCS Level II code for injection, trastuzumab, excludes biosimilar, 10 mg. CMS assigns NDCs for Herceptin to it. One billing unit is 10 mg. The Medicare Part B payment limit is $68.871 per unit (October 1, 2026 through December 31, 2026).

Code

Med-Code curated
HCPCS codeJ9355
Billing unit10 mg
Descriptor
Injection, trastuzumab, excludes biosimilar, 10 mg
Code set
HCPCS Level II, maintained by CMS

Medicare Part B payment limit

CMS ASP file
Payment limit per unit$68.871
Per10 mg
Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 10 mg. For example, 1000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Enter the dose given to build the claim line.

Drugs mapped to J9355

FDA-listed products billed under J9355

Finished products in the FDA NDC Directory whose brand or single active ingredient, and route, match this code’s entry.

NDC products matching J9355
ProductStrengthForm · routeLabelerProduct NDC
HerceptintrastuzumabTrastuzumab 150 mg/7.4mLInjection, Powder, Lyophilized, For solutionIntravenousGenentech, Inc.50242-132
HerzumatrastuzumabTrastuzumab 150 mg/7.15mLInjection, Powder, Lyophilized, For solutionIntravenousCephalon, Inc.63459-303
Kanjintitrastuzumab-annsTrastuzumab 420 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenousAmgen, Inc55513-132
Kanjintitrastuzumab-annsTrastuzumab 150 mg/7.15mLInjection, Powder, Lyophilized, For solutionIntravenousAmgen, Inc55513-141
OgivritrastuzumabTrastuzumab 150 mg/7.4mLInjection, Powder, Lyophilized, For solutionIntravenousMylan Institutional LLC67457-991
Ogivritrastuzumab-dkstTrastuzumab 150 mg/7.4mLInjection, Powder, Lyophilized, For solutionIntravenousBiocon Biologics Inc.83257-001
Ogivritrastuzumab-dkstTrastuzumab 420 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenousBiocon Biologics Inc.83257-003
OntruzanttrastuzumabTrastuzumab 150 mg/1Injection, Powder, Lyophilized, For solutionIntravenousOrganon LLC78206-147
Trazimeratrastuzumab-qyypTrastuzumab 150 mg/7.15mLInjection, Powder, Lyophilized, For solutionIntravenousPfizer Laboratories Div Pfizer Inc0069-0308

All NDCs for these drugs

NDCs billed under J9355

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 1 NDC to J9355 for Herceptin. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J9355 in the CMS ASP crosswalk
DrugNDC (11-digit)LabelerPackageBilling units per package
Herceptin50242-0132-01Genentech, Inc.115

J9355: common questions

Is J9355 a CPT code?
No. J9355 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J9355?
CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under J9355, for Herceptin. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J9355?
$68.871 per 10 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J9355?
One unit of J9355 is 10 mg, as stated in the code's descriptor. Units to report = dose given ÷ 10 mg. J-code billing units.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in